Variable efficacy of recombinant human erythropoietin in anemic pregnant women with different forms of heterozygous hemoglobinopathy. (åpner nytt vindu)

Bencaiova G, Krafft A, Burkhardt T, Breymann C.

Kilde‎: Acta Haematol 2006;116(4):259-65.

Arkiv‎: PubMed 17119327

DOI‎: 10.1159/000095877

https://www.ncbi.nlm.nih.gov/pubmed/17119327 (åpner nytt vindu)

Erythropoietin use in a pregnant Jehovah's Witness with anemia and beta-thalassemia: a case report. (åpner nytt vindu)

Bennett M, Macri CJ, Bathgate SL.

Kilde‎: J Reprod Med 2005;50(2):135-7.

Arkiv‎: PubMed 15755051

https://www.ncbi.nlm.nih.gov/pubmed/15755051 (åpner nytt vindu)

Preliminary results with administration of recombinant human erythropoietin in sickle cell/beta-thalassemia patients during pregnancy. (åpner nytt vindu)

Bourantas K, Makrydimas G, Georgiou J, Tsiara S, Lolis D.

Kilde‎: Eur J Haematol 1996;56(5):326-8.

Arkiv‎: PubMed 8641410

https://www.ncbi.nlm.nih.gov/pubmed/8641410 (åpner nytt vindu)

Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy. (åpner nytt vindu)

Breymann C, Fibach E, Visca E, Huettner C, Huch A, Huch R.

Kilde‎: J Matern Fetal Med 1999;8(1):1-7.

Arkiv‎: PubMed 10052837

DOI‎: 10.1002/(SICI)1520-6661(199901/02)8:1<1::AID-MFM1>3.0.CO;2-O

https://www.ncbi.nlm.nih.gov/pubmed/10052837 (åpner nytt vindu)

Effective treatment of beta-thalassemia intermedia during pregnancy with rHuEpo. A case report. (åpner nytt vindu)

Lialios G, Makrydimas G, Tsanadis G, Lolis D, Bourantas K.

Kilde‎: Minerva Ginecol 2000;52(1-2):29-31.

Arkiv‎: PubMed 10851861

https://www.ncbi.nlm.nih.gov/pubmed/10851861 (åpner nytt vindu)